Feasibility of T2 relaxation time in predicting the technical outcome of MR-guided high-intensity focused ultrasound treatment of uterine fibroids

References

• Stewart EA, Gostout B, Rabinovici J, et al. Sustained relief of leiomyoma symptoms by using focused ultrasound surgery. Obstet Gynecol. 2007;110(2):279–287.
   PubMed Web of Science ®Google Scholar
• Funaki K, Fukunishi H, Funaki T, et al. Mid-term outcome of magnetic resonance-guided focused ultrasound surgery for uterine myomas: from six to twelve months after volume reduction. J Minim Invasive Gynecol. 2007;14(5):616–621.
   PubMed Web of Science ®Google Scholar
• Funaki K, Fukunishi H, Sawada K. Clinical outcomes of magnetic resonance-guided focused ultrasound surgery for uterine myomas: 24-Month follow-up. Ultrasound Obstet Gynecol. 2009;34(5):584–589.
   PubMed Web of Science ®Google Scholar
• Al Hilli M, Stewart E. Magnetic resonance-guided focused ultrasound surgery. Semin Reprod Med. 2010;28(3):242–249.
   PubMed Web of Science ®Google Scholar
• Moore AB, Yu L, Swartz CD, et al. Human uterine leiomyoma-derived fibroblasts stimulate uterine leiomyoma cell proliferation and collagen type i production, and activate RTKs and TGF beta receptor signaling in coculture. Cell Commun Signal. 2010;8:10–12.
   PubMed Web of Science ®Google Scholar
• Wei JJ, Zhang XM, Chiriboga L, et al. Spatial differences in biologic activity of large uterine leiomyomata. Fertil Steril. 2006;85(1):179–187.
   PubMed Web of Science ®Google Scholar
• Jayes FL, Liu B, Feng L, et al. Evidence of biomechanical and collagen heterogeneity in uterine fibroids. PLOS One. 2019;14(4):e0215646–16.
   PubMed Web of Science ®Google Scholar
• Holdsworth-Carson SJ, Zhao D, Cann L, et al. Differences in the cellular composition of small versus large uterine fibroids. Reproduction. 2016;152(5):467–480.
   PubMed Web of Science ®Google Scholar
• Swe TT, Onitsuka H, Kawamoto K, et al. Uterine leiomyoma: correlation between signal intensity on magnetic resonance imaging and pathologic characteristics. Radiat Med. 1992;10(6):235–242.
   PubMedGoogle Scholar
• Oguchi O, Mori A, Kobayashi Y, et al. Prediction of histopathologic features and proliferative activity of uterine leiomyoma by magnetic resonance imaging prior to GnRH analogue therapy: correlation between T2-weighted images and effect of GnRH analogue. J. Obstet. Gynaecol. 1995;21(2):107–117.
   PubMedGoogle Scholar
• Fennessy FM, Tempany CM, McDannold NJ, et al. Uterine leiomyomas: MR imaging–guided focused ultrasound surgery—results of different treatment protocols 1. Radiology. 2007;243(3):885–893.
   PubMed Web of Science ®Google Scholar
• Funaki K, Fukunishi H, Funaki T, et al. Magnetic resonance-guided focused ultrasound surgery for uterine fibroids: relationship between the therapeutic effects and signal intensity of preexisting T2-weighted magnetic resonance images. Am J Obstet Gynecol. 2007;196(2):1–6.
   PubMed Web of Science ®Google Scholar
• Kim Y-S, Keserci B, Partanen A, et al. Volumetric MR-HIFU ablation of uterine fibroids: Role of treatment cell size in the improvement of energy efficiency. Eur J Radiol. 2012;81(11):3652–3659.
   PubMed Web of Science ®Google Scholar
• Kim Y-S, Kim B-G, Rhim H, et al. Uterine fibroids: semiquantitative perfusion MR imaging parameters associated with the intraprocedural and immediate postprocedural treatment efficiencies of MR imaging-guided high-intensity focused ultrasound ablation. Radiology. 2014;273(2):462–471.
   PubMed Web of Science ®Google Scholar
• Wei C, Fang X, Wang CB, et al. The predictive value of quantitative DCE metrics for immediate therapeutic response of high-intensity focused ultrasound ablation (HIFU) of symptomatic uterine fibroids. Abdom Radiol. 2018;43(8):2169–2175.
   Web of Science ®Google Scholar
• Hocquelet A, Denis de Senneville B, Frulio N, et al. Magnetic resonance texture parameters are associated with ablation efficiency in MR-guided high-intensity focussed ultrasound treatment of uterine fibroids. Int J Hyperthermia. 2017;33(2):142–149.
   PubMed Web of Science ®Google Scholar
• Sainio T, Saunavaara J, Komar G, et al. Feasibility of apparent diffusion coefficient in predicting the technical outcome of MR-guided high-intensity focused ultrasound treatment of uterine fibroids–a comparison with the funaki classification. Int J Hyperth. 2021;38(1):85–94.
   PubMed Web of Science ®Google Scholar
• Park H, Yoon SW, Sokolov A. Scaled signal intensity of uterine fibroids based on T2-weighted MR images: a potential objective method to determine the suitability for magnetic resonance-guided focused ultrasound surgery of uterine fibroids. Eur Radiol. 2015;25(12):3455–3458.
   PubMed Web of Science ®Google Scholar
• Bojorquez JZ, Bricq S, Acquitter C, et al. What are normal relaxation times of tissues at 3 T? Magn Reson Imaging. 2017;35:69–80.
   PubMed Web of Science ®Google Scholar
• Hardy PA, Henkelman RM, Bishop JE, et al. Why fat is bright in rare and fast spin-echo imaging. J Magn Reson Imaging. 1992;2(5):533–540.
   PubMed Web of Science ®Google Scholar
• Thangavel K, Saritaş EÜ. Aqueous paramagnetic solutions for MRI phantoms at 3 T: a detailed study on relaxivities. Turk J Elec Eng Comp Sci. 2017;25(3):2108–2121.
   Web of Science ®Google Scholar
• Sainio T, Komar G, Saunavaara J, et al. Wedged gel pad for bowel manipulation during MR-guided high-intensity focused ultrasound therapy to treat uterine fibroids: a case report. J Ther Ultrasound. 2018;6(1):10.
   PubMedGoogle Scholar
• Mindjuk I, Trumm C, Herzog P, et al. MRI predictors of clinical success in MR-guided focused ultrasound (MRgFUS) treatments of uterine fibroids: results from a single Centre. Eur Radiol. 2015;25(5):1317–1328.
   PubMed Web of Science ®Google Scholar
• Stewart EA, Rabinovici J, Tempany CMC, et al. Clinical outcomes of focused ultrasound surgery for the treatment of uterine fibroids. Fertil Steril. 2006;85(1):22–29.
   PubMed Web of Science ®Google Scholar
• Verpalen IM, Anneveldt KJ, Vos PC, et al. Use of multiparametric MRI to characterize uterine fibroid tissue types. MAGMA. 2020;33(5):689–700.
   PubMedGoogle Scholar
• Kim Y-S, Lim HK, Kim J-H, et al. Dynamic contrast-enhanced magnetic resonance imaging predicts immediate therapeutic response of magnetic resonance-guided high-intensity focused ultrasound ablation of symptomatic uterine fibroids. Invest Radiol. 2011;46(10):639–647.
   PubMed Web of Science ®Google Scholar
• Lozinski T, Filipowska J, Krol P, et al. Oxytocin administration in high-intensity focused ultrasound treatment of myomata. Biomed Res Int. 2018;2018:7518026.
   PubMed Web of Science ®Google Scholar
• Otonkoski S, Sainio T, Komar G, et al. Oxytocin selectively reduces blood flow in uterine fibroids without an effect on myometrial blood flow: a dynamic contrast enhanced MRI evaluation. Int J Hyperthermia. 2020;37(1):1293–1300.
   PubMed Web of Science ®Google Scholar
• Suomi V, Komar G, Sainio T, et al. Comprehensive feature selection for classifying the treatment outcome of high-intensity ultrasound therapy in uterine fibroids. Sci Rep. 2019;9(1):1–11.
   PubMed Web of Science ®Google Scholar